DarioHealth Corp. (DRIO) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Electromed, Inc.

Apyx Medical Corp.

KORU Medical Systems, Inc.

Hyperfine, Inc.

Inogen, Inc.

DarioHealth Corp.

Stereotaxis, Inc.

Citius Pharmaceuticals, Inc.

Accelerate Diagnostics, Inc.

Cutera, Inc.

Clearpoint Neuro, Inc.

Why is DarioHealth Corp. ?

Flat results in Mar 26

INTEREST(HY) At USD 2.51 MM has Grown at 4,389.29%
NET SALES(HY) At USD 10.81 MM has Grown at -24.67%
CASH AND EQV(HY) Lowest at USD 46.51 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -29.73%, its profits have risen by 26.1%

Underperformed the market in the last 1 year

Even though the market (S&P 500) has generated returns of 21.51% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -29.73% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is DarioHealth Corp. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

DarioHealth Corp.

-29.73%

0.23

2054.35%

S&P 500

21.51%

1.63

13.19%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

24.15%

EBIT Growth (5y)

-5.00%

EBIT to Interest (avg)

-47.13

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.02

Sales to Capital Employed (avg)

0.24

Tax Ratio

0.37%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

15.50%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.87

EV to EBIT

-1.75

EV to EBITDA

-1.94

EV to Capital Employed

0.88

EV to Sales

2.87

PEG Ratio

Dividend Yield

ROCE (Latest)

-50.31%

ROE (Latest)

-45.02%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -25.29 MM

NET PROFIT(HY)

Higher at USD -24.09 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 7.81 times

RAW MATERIAL COST(Y)

Fallen by 0.32% (YoY

OPERATING PROFIT(Q)

Highest at USD -6.67 MM

OPERATING PROFIT MARGIN(Q)

Highest at -119.54 %

PRE-TAX PROFIT(Q)

Highest at USD -8.37 MM

EPS(Q)

Highest at USD -1.25

-16What is not working for the Company

INTEREST(HY)

At USD 2.51 MM has Grown at 4,389.29%

NET SALES(HY)

At USD 10.81 MM has Grown at -24.67%

CASH AND EQV(HY)

Lowest at USD 46.51 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.09 times

Here's what is working for DarioHealth Corp.

Operating Cash Flow

Highest at USD -25.29 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit

Higher at USD -24.09 MM

than preceding 12 month period ended Mar 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Debtors Turnover Ratio

Highest at 7.81 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Operating Profit

Highest at USD -6.67 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin

Highest at -119.54 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at USD -8.37 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

EPS

Highest at USD -1.25

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by 0.32% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for DarioHealth Corp.

Interest

At USD 2.51 MM has Grown at 4,389.29%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Net Sales

At USD 10.81 MM has Grown at -24.67%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)

Cash and Eqv

Lowest at USD 46.51 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Inventory Turnover Ratio

Lowest at 2.09 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio